Alkermes completes merger with Elan Medication Technologies Alkermes plc and Elan Corporation.

That they own. Additional information regarding the exchange of Alkermes, Inc. Common share will be mailed to registered holders of Alkermes, Inc. Common share. Alkermes shareholders who keep shares through a broker or bank should receive information relating to the exchange or transformation of their shares from the organization holding their shares.. Alkermes completes merger with Elan Medication Technologies Alkermes plc and Elan Corporation, plc today announced the completion of the merger between Alkermes, Inc. And Elan Medication Technologies , the medication formulation and manufacturing business device of Elan, following the acceptance of the merger by Alkermes, Inc.This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health Information, an editorially independent news service, is an application of the Kaiser Family Foundation, a nonpartisan healthcare policy research organization unaffiliated with Kaiser Permanente.

April In, AOAC Analysis Institute granted PTM SM certification of the Salmonella assay, another important confirmation of the technology's effectiveness in detecting the bacterias.S. And also Europe recently, so being able to offer such a very simple and quick assay for that pathogen that stands up to the rigor of AFNOR Certification criteria is an integral development for meals processors based throughout the world, said Marie-Pierre Copin, 3M Food Safety's European regulatory affairs specialist.